(1)
In Silico Insights into the Impact of Deleterious SNPs on the Functioning and Dynamics of TP53 and Its Targeted Therapy by COTI-2 and PRIMA1 in Breast Cancer Patients. UCP J. Sci. Technol. 2026, 3 (2), 31-58. https://doi.org/10.24312/ucp-jst.03.02.523.